<DOC>
	<DOCNO>NCT02935725</DOCNO>
	<brief_summary>A Phase 1 , Single-centre , Double-blind , Placebo control Crossover Study Assess pharmacoMRI Effects AUT00206 Healthy Male Participants</brief_summary>
	<brief_title>A Study Assess pharmacoMRI Effects AUT00206 Healthy Males</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Male age 18 45 year , inclusive Visit 1 . Healthy basis medical history , psychiatric history , physical examination , vital sign , 12lead electrocardiogram ( ECG ) , haematology , blood chemistry urinalysis within 6 week Visit 2 . Righthanded . Not regular smoker ( maximum 5 cigarette per week equivalent ) . History , current condition , migraine headache undergone operation head . History significant claustrophobia .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>